CPT code 96912 represents photochemotherapy (PUVA) using psoralens plus ultraviolet A light to manage chronic dermatologic conditions such as psoriasis and vitiligo. Nationally, PUVA remains a clinically important option for patients who have not responded to first-line topical or phototherapy approaches; accurate coding for 96912 matters for clinical documentation, appropriate utilization tracking, and payer adjudication.

Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for PUVA therapy, common sites of service where the procedure is delivered, and benchmarking and coverage themes that influence payment and utilization. The publication outlines typical billing considerations for outpatient dermatology settings and highlights policy updates and payer practices that affect prior authorization, medical necessity determinations, and bundling rules.

This summary equips clinicians, billers, and policy analysts with essential information about CPT code 96912, clarifies the clinical role of PUVA therapy, and frames the reimbursement and coverage environment at a national level. Data not available in the input will be noted where applicable in supporting sections.